1. Enzyme replacement therapies: what is the best option?

Azam Safary , Mostafa Akbarzadeh Khiavi , Rahimeh Mousavi, Jaleh Barar , Mohammad A Rafi*

Bioimpacts. 2018;8(3): 153-157. doi: 10.15171/bi.2018.17

PMCID: PMC6128977 PMID: 30211074 Scopus ID: 85050655722

Article

PDF

Full Text

XML

Cited By:

Editorial

2. Targeted delivery of thrombolytic enzymes

Young M. Kwon*

BioImpacts. 2021;11(2): 85-86. doi: 10.34172/bi.2021.15

PMCID: PMC8022233 PMID: 33842278 Scopus ID: 85106598035

Article

PDF

Full Text

XML

Cited By:

Young M. Kwon received his Ph.D. from University of Utah (USA) and his postdoctoral training at University of Michigan (USA). He is currently an Associate Professor of Pharmaceutical Sciences at Nova Southeastern University College of Pharmacy (USA). Dr. Kwon’s research interests include targeted delivery and controlled release of biological molecules.

Editorial

3. Dual-targeting of brain tumors with nanovesicles

Nazanin Kianinejad , Young Min Kwon*

Bioimpacts. 2023;13(1): 1-3. doi: 10.34172/bi.2022.26321

PMCID: PMC9923813 PMID: 36816997 Scopus ID: 85152111029

Article

PDF

Full Text

XML

Cited By:

Young M. Kwon is an associate professor of Pharmaceutical Sciences at Nova Southeastern University, College of Pharmacy (USA). Dr. Kwon’s research interests include targeted delivery and controlled release of biological molecules.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons